Showing results (341-350 of 358) with videos related to

Sort By:
Pageof 36
ACS Infectious Diseases|May 24, 2022
Pyronaridine Protects against SARS-CoV-2 Infection in MouseAna C Puhl, Giovanni F Gomes, Samara Damasceno, et al.
Scientific Reports|February 18, 2018
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanKLaurent R Chiarelli, Giorgia Mori, Beatrice Silvia Orena, et al.
Scientific Reports|November 29, 2019
A diarylamine derived from anthranilic acid inhibits ZIKV replicationSuely Silva, Jacqueline Farinha Shimizu, Débora Moraes de Oliveira, et al.
ACS Infectious Diseases|March 20, 2025
Mycobacterium tuberculosis Sulfate Ester Dioxygenase Rv3406 Is Able to Inactivate the RCB18350 CompoundDeborah Recchia, Giovanni Stelitano, Anna Egorova, et al.
ACS Omega|September 13, 2022
Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected MiceAna C Puhl, Giovanni F Gomes, Samara Damasceno, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
Vandetanib Reduces Inflammatory Cytokines and Ameliorates COVID-19 in Infected MiceAna C Puhl, Giovanni F Gomes, Samara Damasceno, et al.
Bioorganic Chemistry|February 6, 2022
Chalcones from Angelica keiskei (ashitaba) inhibit key Zika virus replication proteinsMelina Mottin, Lindsay K Caesar, David Brodsky, et al.
Cell Chemical Biology|November 13, 2019
Antitubercular Triazines: Optimization and Intrabacterial MetabolismXin Wang, Daigo Inoyama, Riccardo Russo, et al.
Tuberculosis (Edinburgh, Scotland)|September 13, 2018
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymeraseGiorgia Mori, Beatrice Silvia Orena, Clara Franch, et al.
Biorxiv : the Preprint Server for Biology|December 10, 2020
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential MechanismsAna C Puhl, Ethan James Fritch, Thomas R Lane, et al.
Pageof 36